ns1209
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2005 (NCT00258622)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Glutamate receptor-interacting protein 1ANTAGONIST
GRIP1 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 8-methyl-5-(4-(n,n-dimethylsulfamoyl)phenyl)-6,7,8,9,-tetrahydro-1h-pyrrolo(3,2-h)-isoquinoline-2,3-dione-3-o-(4-hydroxybutyric acid-2-yl)oxime
- ns1209
- ns1209
- ns1209
- spd502
- spd 502
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00258622 | Phase 2 | Nov 1, 2005 | Aarhus University, NeuroSearch A/S |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aarhus University | Academic/Hospital | 1 | 1 | 1 | 2005 |
| NeuroSearch A/S | For profit | 1 | 0 | 1 | 2005 |
2 organizations
Page 1 / 1